Aveanna Healthcare (NASDAQ:AVAH) Insider Patrick Cunningham Sells 17,965 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Patrick Cunningham sold 17,965 shares of the stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $7.38, for a total transaction of $132,581.70. Following the transaction, the insider owned 356,191 shares in the company, valued at approximately $2,628,689.58. This trade represents a 4.80% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Aveanna Healthcare Stock Up 0.3%

Shares of Aveanna Healthcare stock traded up $0.02 during midday trading on Thursday, reaching $7.42. 3,877,110 shares of the company’s stock traded hands, compared to its average volume of 938,081. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.67 and a 52 week high of $10.32. The company’s 50 day simple moving average is $8.48 and its 200 day simple moving average is $8.44. The company has a market cap of $1.55 billion, a price-to-earnings ratio of 20.61 and a beta of 2.06.

Institutional Trading of Aveanna Healthcare

A number of large investors have recently bought and sold shares of AVAH. Quantbot Technologies LP bought a new position in shares of Aveanna Healthcare during the second quarter valued at $43,000. MQS Management LLC acquired a new position in Aveanna Healthcare in the second quarter valued at about $59,000. Belvedere Trading LLC bought a new stake in Aveanna Healthcare during the second quarter worth about $62,000. Oxford Asset Management LLP bought a new stake in Aveanna Healthcare during the second quarter worth about $64,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Aveanna Healthcare during the second quarter worth approximately $68,000. 87.96% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

AVAH has been the subject of several recent analyst reports. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 3rd. Jefferies Financial Group boosted their price objective on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. UBS Group lifted their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, January 15th. William Blair started coverage on shares of Aveanna Healthcare in a report on Monday, December 8th. They issued an “outperform” rating for the company. Finally, Raymond James Financial reissued an “outperform” rating and set a $13.00 price objective on shares of Aveanna Healthcare in a report on Friday, December 5th. Five investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Aveanna Healthcare currently has an average rating of “Hold” and a consensus target price of $11.06.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.